Non-alcoholic fatty liver disease (NAFLD) is a type of steatosis commonly associated with
obesity, dyslipidemia, hypertension, and diabetes. Other diseases such as inherited alpha-1 …

Background Some anthropometric, laboratory, and genetic variations, such as patatin-like
phospholipase domain-containing protein 3 (PNPLA3) genetic variants, have been …

The utilization of evolutive models and algorithms for predicting the evolution of hepatic
steatosis holds immense potential benefits. These computational approaches enable the …

Background and Objectives: Non-alcoholic fatty liver disease (NAFLD) is associated with
obesity and ranges from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis …

Abstract Lactiplantibacillus plantarum DSR330 (DSR330) has been examined for its
antimicrobials production and probiotics. In this study, the hepatoprotective effects of …

Background and Objectives: Metabolic-dysfunction-associated steatotic liver disease or
MASLD is the main cause of chronic liver diseases in children, and it is estimated to affect …

Dyglomera® is an aqueous ethanol extract of the fruit pods of Dichrostachys glomerata, a
Cameroonian spice. Several studies have shown its anti-diabetic and anti-obesity effects …

The status of vitamin D in underground working coal miners and its association with their
cardiometabolic health is rarely studied. This study aimed to examine vitamin D (VitD) status …

Non-alcoholic fatty liver disease (NAFLD) is marked by the excessive intrusion of
triglycerides into hepatocytes without any role of alcohol consumption. Various risk factors …

Non-alcoholic fatty liver disease (NAFLD), a complex liver disorder that can result in non-
alcoholic steatohepatitis, cirrhosis, and liver cancer, is the accumulation of fat in the liver …